Key result
This review examines the mechanisms of action and current evidence regarding the continuation of clopidogrel and other anticoagulant or antiplatelet medications during skin surgery procedures.
Why the study?
Does continuing clopidogrel during skin surgery increase the risk of perioperative and postoperative bleeding?
Does continuing clopidogrel during skin surgery increase the risk of perioperative and postoperative bleeding?
This review examines the mechanisms and evidence regarding the continuation of clopidogrel and other bleeding-risk medications during skin surgery.
Review of antiplatelet continuation in skin surgery highlights bleeding risks; leaves open optimal perioperative strategies.
Patients who have skin surgery may be taking medication that increases the likelihood of bleeding, such as clopidogrel, aspirin, warfarin, heparin and nonsteroidal anti-inflammatory drugs (NSAIDS). All of these may increase the risk of perioperative and postoperative bleeding. This article examines the mechanism of action of clopidogrel, current practice, and evidence for or against continuing its use during skin surgery. The mechanisms of action of aspirin, warfarin, heparin and NSAIDS will also be briefly discussed.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2009) conducted a review in Skin surgery in patients taking medications that increase bleeding risk. Clopidogrel was evaluated. This review examines the mechanisms of action and current evidence regarding the continuation of clopidogrel and other anticoagulant or antiplatelet medications during skin surgery procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: